VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q41598141 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010712.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q41598141‏
024 ‎‡a 0000-0001-6955-7374‏ ‎‡2 orcid‏
035 ‎‡a (OCoLC)Q41598141‏
100 0 ‎‡a Thomas R Schneider‏ ‎‡9 sl‏ ‎‡9 es‏ ‎‡9 ast‏
375 ‎‡a 1‏ ‎‡2 iso5218‏
400 0 ‎‡a Thomas Schneider‏ ‎‡9 fr‏ ‎‡9 co‏ ‎‡9 pt‏ ‎‡9 ty‏ ‎‡9 da‏ ‎‡9 de‏ ‎‡9 it‏ ‎‡9 sk‏ ‎‡9 pt-br‏ ‎‡9 br‏ ‎‡9 cs‏ ‎‡9 nl‏ ‎‡9 nds‏ ‎‡9 ro‏ ‎‡9 id‏ ‎‡9 pl‏
400 0 ‎‡a Thomas Schneider‏ ‎‡c researcher (ORCID 0000-0001-6955-7374)‏ ‎‡9 en‏
400 0 ‎‡a Thomas Schneider‏ ‎‡c forskare‏ ‎‡9 sv‏
670 ‎‡a Author's 3-Sulfinopropionyl-coenzyme A (3SP-CoA) desulfinase from Advenella mimigardefordensis DPN7(T): crystal structure and function of a desulfinase with an acyl-CoA dehydrogenase fold‏
670 ‎‡a Author's A genetic algorithm for the identification of conformationally invariant regions in protein molecules‏
670 ‎‡a Author's A multicrystal diffraction data-collection approach for studying structural dynamics with millisecond temporal resolution‏
670 ‎‡a Author's A novel β-xylosidase structure from Geobacillus thermoglucosidasius: the first crystal structure of a glycoside hydrolase family GH52 enzyme reveals unpredicted similarity to other glycoside hydrolase folds‏
670 ‎‡a Author's A subgroup of light-driven sodium pumps with an additional Schiff base counterion‏
670 ‎‡a Author's A test of the validity of the method of constant stimuli as an index of heartbeat detection‏
670 ‎‡a Author's Alignment of protein structures in the presence of domain motions‏
670 ‎‡a Author's Alumoxane Hydride and Aluminum Chalcogenide Hydride Compounds with Pyrazolato Ligands‏
670 ‎‡a Author's Automatic Solution of Heavy-Atom Substructures‏
670 ‎‡a Author's Comparison of different X-ray data-collection systems using the crystal structure of octreotide.‏
670 ‎‡a Author's Contribution of the intramolecular disulfide bridge to the folding stability of REIv, the variable domain of a human immunoglobulin kappa light chain.‏
670 ‎‡a Author's Core Mediator structure at 3.4 Å extends model of transcription initiation complex‏
670 ‎‡a Author's Crystal structure of domain A of Thermus flavus 5S rRNA and the contribution of water molecules to its structure‏
670 ‎‡a Author's Crystal structure of the endosomal SNARE complex reveals common structural principles of all SNAREs‏
670 ‎‡a Author's Crystal Structure of the Gamma-2 Herpesvirus LANA DNA Binding Domain Identifies Charged Surface Residues Which Impact Viral Latency‏
670 ‎‡a Author's Crystal structure of the ubiquitin binding domains of rabex-5 reveals two modes of interaction with ubiquitin‏
670 ‎‡a Author's Data collection with a tailored X-ray beam size at 2.69 Å wavelength (4.6 keV): sulfur SAD phasing of Cdc23(Nterm).‏
670 ‎‡a Author's Evolution of feedback-inhibited / barrel isoenzymes by gene duplication and a single mutation‏
670 ‎‡a Author's Identification of the point of diminishing returns in high-multiplicity data collection for sulfur SAD phasing‏
670 ‎‡a Author's Influence of internal dynamics on accuracy of protein NMR structures: derivation of realistic model distance data from a long molecular dynamics trajectory.‏
670 ‎‡a Author's Mechanism of Aurora B activation by INCENP and inhibition by hesperadin‏
670 ‎‡a Author's Microfluidic Chips for In Situ Crystal X-ray Diffraction and In Situ Dynamic Light Scattering for Serial Crystallography‏
670 ‎‡a Author's Molecular basis for redox-Bohr and cooperative effects in cytochrome c3 from Desulfovibrio desulfuricans ATCC 27774: crystallographic and modeling studies of oxidized and reduced high-resolution structures at pH 7.6‏
670 ‎‡a Author's MXCuBE2: the dawn of MXCuBE Collaboration‏
670 ‎‡a Author's Optimization of selenium substructures as obtained from SHELXD.‏
670 ‎‡a Author's P13, the EMBL macromolecular crystallography beamline at the low-emittance PETRA III ring for high- and low-energy phasing with variable beam focusing‏
670 ‎‡a Author's RAPIDO: a web server for the alignment of protein structures in the presence of conformational changes.‏
670 ‎‡a Author's Rat ceruloplasmin: a new labile copper binding site and zinc/copper mosaic.‏
670 ‎‡a Author's Refinement of triclinic hen egg-white lysozyme at atomic resolution‏
670 ‎‡a Author's SCEDS: protein fragments for molecular replacement in Phaser‏
670 ‎‡a Author's Serial crystallography onin vivogrown microcrystals using synchrotron radiation‏
670 ‎‡a Author's Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase‏
670 ‎‡a Author's Structural information content at high resolution: MAD versus native‏
670 ‎‡a Author's Structure of balhimycin and its complex with solvent molecules‏
670 ‎‡a Author's Structure of catalase HPII from Escherichia coli at 1.9 A resolution‏
670 ‎‡a Author's Structure of Ecballium elaterium trypsin inhibitor II‏
670 ‎‡a Author's Structure of Ecballium elaterium trypsin inhibitor II (EETI-II): a rigid molecular scaffold‏
670 ‎‡a Author's Structure of the Alpha -amylase inhibitor tendamistat at 0.93 A‏
670 ‎‡a Author's Subatomic and atomic crystallographic studies of aldose reductase: implications for inhibitor binding.‏
670 ‎‡a Author's Substrate and metal complexes of 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase from Saccharomyces cerevisiae provide new insights into the catalytic mechanism‏
670 ‎‡a Author's Synchrotron radiation: micrometer-sized x-ray beams as fine tools for macromolecular crystallography‏
670 ‎‡a Author's Terahertz radiation induces non-thermal structural changes associated with Fröhlich condensation in a protein crystal.‏
670 ‎‡a Author's The crystallographic structure of the aldose reductase-IDD552 complex shows direct proton donation from tyrosine 48‏
670 ‎‡a Author's The First Structurally Characterized Aluminum Compounds with Terminal Acetylide Groups This work was supported by the Deutsche Forschungsgemeinschaft. N.C.M.-Z. thanks the Schweizerischer Nationalfonds for a fellowship‏
670 ‎‡a Author's The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design‏
670 ‎‡a Author's Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66 A‏
670 ‎‡a Author's Ultrahigh resolution drug design. II. Atomic resolution structures of human aldose reductase holoenzyme complexed with Fidarestat and Minalrestat: implications for the binding of cyclic imide inhibitors‏
670 ‎‡a Author's Ultrahigh-resolution study of protein atomic displacement parameters at cryotemperatures obtained with a helium cryostat‏
670 ‎‡a Author's Visualization of protein crystals by high-energy phase-contrast X-ray imaging‏
670 ‎‡a Author's X-ray crystallography reveals stringent conservation of protein fold after removal of the only disulfide bridge from a stabilized immunoglobulin variable domain‏
670 ‎‡a Author's X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease‏
670 ‎‡a Author's X-ray snapshots of serine protease catalysis reveal a tetrahedral intermediate‏
670 ‎‡a Author's X-ray structure determination of a metastable state of carbonmonoxy myoglobin after photodissociation.‏
909 ‎‡a (orcid) 0000000169557374‏ ‎‡9 1‏
919 ‎‡a structureofcatalasehpiifromescherichiacoliat19aresolution‏ ‎‡A Structure of catalase HPII from Escherichia coli at 1.9 A resolution‏ ‎‡9 1‏
919 ‎‡a structureofecballiumelateriumtrypsininhibitor2‏ ‎‡A Structure of Ecballium elaterium trypsin inhibitor II‏ ‎‡9 1‏
919 ‎‡a structureofecballiumelateriumtrypsininhibitor2eeti2arigidmolecularscaffold‏ ‎‡A Structure of Ecballium elaterium trypsin inhibitor II (EETI-II): a rigid molecular scaffold‏ ‎‡9 1‏
919 ‎‡a structureofthe Alpha amylaseinhibitortendamistatat093a‏ ‎‡A Structure of the Alpha -amylase inhibitor tendamistat at 0.93 A‏ ‎‡9 1‏
919 ‎‡a subatomicandatomiccrystallographicstudiesofaldosereductaseimplicationsforinhibitorbinding‏ ‎‡A Subatomic and atomic crystallographic studies of aldose reductase: implications for inhibitor binding.‏ ‎‡9 1‏
919 ‎‡a substrateandmetalcomplexesof3deoxy500arabinoheptulosonate7phosphatesynthasefromsaccharomycescerevisiaeprovidenewinsightsintothecatalyticmechanism‏ ‎‡A Substrate and metal complexes of 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase from Saccharomyces cerevisiae provide new insights into the catalytic mechanism‏ ‎‡9 1‏
919 ‎‡a synchrotronradiationmicrometersized10raybeamsasfinetoolsformacromolecularcrystallography‏ ‎‡A Synchrotron radiation: micrometer-sized x-ray beams as fine tools for macromolecular crystallography‏ ‎‡9 1‏
919 ‎‡a terahertzradiationinducesnonthermalstructuralchangesassociatedwithfrohlichcondensationinaproteincrystal‏ ‎‡A Terahertz radiation induces non-thermal structural changes associated with Fröhlich condensation in a protein crystal.‏ ‎‡9 1‏
919 ‎‡a crystallographicstructureofthealdosereductaseidd552complexshowsdirectprotondonationfromtyrosine48‏ ‎‡A The crystallographic structure of the aldose reductase-IDD552 complex shows direct proton donation from tyrosine 48‏ ‎‡9 1‏
919 ‎‡a 1structurallycharacterizedaluminumcompoundswithterminalacetylidegroupsthisworkwassupportedbythedeutscheforschungsgemeinschaftn1001000zthankstheschweizerischernationalfondsforafellowship‏ ‎‡A The First Structurally Characterized Aluminum Compounds with Terminal Acetylide Groups This work was supported by the Deutsche Forschungsgemeinschaft. N.C.M.-Z. thanks the Schweizerischer Nationalfonds for a fellowship‏ ‎‡9 1‏
919 ‎‡a inhibitionmechanismofhuman20sproteasomesenablesnextgenerationinhibitordesign‏ ‎‡A The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design‏ ‎‡9 1‏
919 ‎‡a ultrahighresolutiondrugdesign1detailsofinteractionsinhumanaldosereductaseinhibitorcomplexat066a‏ ‎‡A Ultrahigh resolution drug design I: details of interactions in human aldose reductase-inhibitor complex at 0.66 A‏ ‎‡9 1‏
919 ‎‡a ultrahighresolutiondrugdesign2atomicresolutionstructuresofhumanaldosereductaseholoenzymecomplexedwithfidarestatandminalrestatimplicationsforthebindingofcyclicimideinhibitors‏ ‎‡A Ultrahigh resolution drug design. II. Atomic resolution structures of human aldose reductase holoenzyme complexed with Fidarestat and Minalrestat: implications for the binding of cyclic imide inhibitors‏ ‎‡9 1‏
919 ‎‡a ultrahighresolutionstudyofproteinatomicdisplacementparametersatcryotemperaturesobtainedwithaheliumcryostat‏ ‎‡A Ultrahigh-resolution study of protein atomic displacement parameters at cryotemperatures obtained with a helium cryostat‏ ‎‡9 1‏
919 ‎‡a visualizationofproteincrystalsbyhighenergyphasecontrast10rayimaging‏ ‎‡A Visualization of protein crystals by high-energy phase-contrast X-ray imaging‏ ‎‡9 1‏
919 ‎‡a 10raycrystallographyrevealsstringentconservationofproteinfoldafterremovaloftheonlydisulfidebridgefromastabilizedimmunoglobulinvariabledomain‏ ‎‡A X-ray crystallography reveals stringent conservation of protein fold after removal of the only disulfide bridge from a stabilized immunoglobulin variable domain‏ ‎‡9 1‏
919 ‎‡a 10rayscreeningidentifiesactivesiteandallostericinhibitorsofsarscov2mainprotease‏ ‎‡A X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease‏ ‎‡9 1‏
919 ‎‡a 10raysnapshotsofserineproteasecatalysisrevealatetrahedralintermediate‏ ‎‡A X-ray snapshots of serine protease catalysis reveal a tetrahedral intermediate‏ ‎‡9 1‏
919 ‎‡a 10raystructuredeterminationofametastablestateofcarbonmonoxymyoglobinafterphotodissociation‏ ‎‡A X-ray structure determination of a metastable state of carbonmonoxy myoglobin after photodissociation.‏ ‎‡9 1‏
919 ‎‡a 3sulfinopropionylcoenzymea3spcoadesulfinasefromadvenellamimigardefordensisdpn7tcrystalstructureandfunctionofadesulfinasewithanacylcoadehydrogenasefold‏ ‎‡A 3-Sulfinopropionyl-coenzyme A (3SP-CoA) desulfinase from Advenella mimigardefordensis DPN7(T): crystal structure and function of a desulfinase with an acyl-CoA dehydrogenase fold‏ ‎‡9 1‏
919 ‎‡a geneticalgorithmfortheidentificationofconformationallyinvariantregionsinproteinmolecules‏ ‎‡A A genetic algorithm for the identification of conformationally invariant regions in protein molecules‏ ‎‡9 1‏
919 ‎‡a multicrystaldiffractiondatacollectionapproachforstudyingstructuraldynamicswithmillisecondtemporalresolution‏ ‎‡A A multicrystal diffraction data-collection approach for studying structural dynamics with millisecond temporal resolution‏ ‎‡9 1‏
919 ‎‡a novelβxylosidasestructurefromgeobacillusthermoglucosidasiusthe1crystalstructureofaglycosidehydrolasefamilygh52enzymerevealsunpredictedsimilaritytootherglycosidehydrolasefolds‏ ‎‡A A novel β-xylosidase structure from Geobacillus thermoglucosidasius: the first crystal structure of a glycoside hydrolase family GH52 enzyme reveals unpredicted similarity to other glycoside hydrolase folds‏ ‎‡9 1‏
919 ‎‡a subgroupoflightdrivensodiumpumpswithanadditionalschiffbasecounterion‏ ‎‡A A subgroup of light-driven sodium pumps with an additional Schiff base counterion‏ ‎‡9 1‏
919 ‎‡a testofthevalidityofthemethodofconstantstimuliasanindexofheartbeatdetection‏ ‎‡A A test of the validity of the method of constant stimuli as an index of heartbeat detection‏ ‎‡9 1‏
919 ‎‡a alignmentofproteinstructuresinthepresenceofdomainmotions‏ ‎‡A Alignment of protein structures in the presence of domain motions‏ ‎‡9 1‏
919 ‎‡a alumoxanehydrideandaluminumchalcogenidehydridecompoundswithpyrazolatoligands‏ ‎‡A Alumoxane Hydride and Aluminum Chalcogenide Hydride Compounds with Pyrazolato Ligands‏ ‎‡9 1‏
919 ‎‡a automaticsolutionofheavyatomsubstructures‏ ‎‡A Automatic Solution of Heavy-Atom Substructures‏ ‎‡9 1‏
919 ‎‡a comparisonofdifferent10raydatacollectionsystemsusingthecrystalstructureofoctreotide‏ ‎‡A Comparison of different X-ray data-collection systems using the crystal structure of octreotide.‏ ‎‡9 1‏
919 ‎‡a contributionoftheintramoleculardisulfidebridgetothefoldingstabilityofreivthevariabledomainofahumanimmunoglobulinkappalightchain‏ ‎‡A Contribution of the intramolecular disulfide bridge to the folding stability of REIv, the variable domain of a human immunoglobulin kappa light chain.‏ ‎‡9 1‏
919 ‎‡a coremediatorstructureat34aextendsmodeloftranscriptioninitiationcomplex‏ ‎‡A Core Mediator structure at 3.4 Å extends model of transcription initiation complex‏ ‎‡9 1‏
919 ‎‡a crystalstructureofdomainaofthermusflavus5srrnaandthecontributionofwatermoleculestoitsstructure‏ ‎‡A Crystal structure of domain A of Thermus flavus 5S rRNA and the contribution of water molecules to its structure‏ ‎‡9 1‏
919 ‎‡a crystalstructureoftheendosomalsnarecomplexrevealscommonstructuralprinciplesofallsnares‏ ‎‡A Crystal structure of the endosomal SNARE complex reveals common structural principles of all SNAREs‏ ‎‡9 1‏
919 ‎‡a crystalstructureofthegamma2herpesviruslanadnabindingdomainidentifieschargedsurfaceresidueswhichimpactvirallatency‏ ‎‡A Crystal Structure of the Gamma-2 Herpesvirus LANA DNA Binding Domain Identifies Charged Surface Residues Which Impact Viral Latency‏ ‎‡9 1‏
919 ‎‡a crystalstructureoftheubiquitinbindingdomainsofrabex5reveals2modesofinteractionwithubiquitin‏ ‎‡A Crystal structure of the ubiquitin binding domains of rabex-5 reveals two modes of interaction with ubiquitin‏ ‎‡9 1‏
919 ‎‡a datacollectionwithatailored10raybeamsizeat269awavelength46kevsulfursadphasingofcdc23nterm‏ ‎‡A Data collection with a tailored X-ray beam size at 2.69 Å wavelength (4.6 keV): sulfur SAD phasing of Cdc23(Nterm).‏ ‎‡9 1‏
919 ‎‡a evolutionoffeedbackinhibitedbarrelisoenzymesbygeneduplicationandasinglemutation‏ ‎‡A Evolution of feedback-inhibited / barrel isoenzymes by gene duplication and a single mutation‏ ‎‡9 1‏
919 ‎‡a identificationofthepointofdiminishingreturnsinhighmultiplicitydatacollectionforsulfursadphasing‏ ‎‡A Identification of the point of diminishing returns in high-multiplicity data collection for sulfur SAD phasing‏ ‎‡9 1‏
919 ‎‡a influenceofinternaldynamicsonaccuracyofproteinnmrstructuresderivationofrealisticmodeldistancedatafromalongmoleculardynamicstrajectory‏ ‎‡A Influence of internal dynamics on accuracy of protein NMR structures: derivation of realistic model distance data from a long molecular dynamics trajectory.‏ ‎‡9 1‏
919 ‎‡a mechanismofaurorabactivationbyincenpandinhibitionbyhesperadin‏ ‎‡A Mechanism of Aurora B activation by INCENP and inhibition by hesperadin‏ ‎‡9 1‏
919 ‎‡a microfluidicchipsforinsitucrystal10raydiffractionandinsitudynamiclightscatteringforserialcrystallography‏ ‎‡A Microfluidic Chips for In Situ Crystal X-ray Diffraction and In Situ Dynamic Light Scattering for Serial Crystallography‏ ‎‡9 1‏
919 ‎‡a molecularbasisforredoxbohrandcooperativeeffectsincytochromec3fromdesulfovibriodesulfuricansatcc27774crystallographicandmodelingstudiesofoxidizedandreducedhighresolutionstructuresatph76‏ ‎‡A Molecular basis for redox-Bohr and cooperative effects in cytochrome c3 from Desulfovibrio desulfuricans ATCC 27774: crystallographic and modeling studies of oxidized and reduced high-resolution structures at pH 7.6‏ ‎‡9 1‏
919 ‎‡a mxcube2thedawnofmxcubecollaboration‏ ‎‡A MXCuBE2: the dawn of MXCuBE Collaboration‏ ‎‡9 1‏
919 ‎‡a optimizationofseleniumsubstructuresasobtainedfromshelxd‏ ‎‡A Optimization of selenium substructures as obtained from SHELXD.‏ ‎‡9 1‏
919 ‎‡a p13theemblmacromolecularcrystallographybeamlineatthelowemittancepetra3ringforhighandlowenergyphasingwithvariablebeamfocusing‏ ‎‡A P13, the EMBL macromolecular crystallography beamline at the low-emittance PETRA III ring for high- and low-energy phasing with variable beam focusing‏ ‎‡9 1‏
919 ‎‡a rapidoawebserverforthealignmentofproteinstructuresinthepresenceofconformationalchanges‏ ‎‡A RAPIDO: a web server for the alignment of protein structures in the presence of conformational changes.‏ ‎‡9 1‏
919 ‎‡a ratceruloplasminanewlabilecopperbindingsiteandzinccoppermosaic‏ ‎‡A Rat ceruloplasmin: a new labile copper binding site and zinc/copper mosaic.‏ ‎‡9 1‏
919 ‎‡a refinementoftriclinicheneggwhitelysozymeatatomicresolution‏ ‎‡A Refinement of triclinic hen egg-white lysozyme at atomic resolution‏ ‎‡9 1‏
919 ‎‡a scedsproteinfragmentsformolecularreplacementinphaser‏ ‎‡A SCEDS: protein fragments for molecular replacement in Phaser‏ ‎‡9 1‏
919 ‎‡a serialcrystallographyoninvivogrownmicrocrystalsusingsynchrotronradiation‏ ‎‡A Serial crystallography onin vivogrown microcrystals using synchrotron radiation‏ ‎‡9 1‏
919 ‎‡a structuralbasisfortheautoinhibitionandsti571inhibitionof100kittyrosinekinase‏ ‎‡A Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase‏ ‎‡9 1‏
919 ‎‡a structuralinformationcontentathighresolutionmadversusnative‏ ‎‡A Structural information content at high resolution: MAD versus native‏ ‎‡9 1‏
919 ‎‡a structureofbalhimycinanditscomplexwithsolventmolecules‏ ‎‡A Structure of balhimycin and its complex with solvent molecules‏ ‎‡9 1‏
946 ‎‡a b‏ ‎‡9 1‏
996 ‎‡2 RERO|A003803540
996 ‎‡2 LC|n 82064732
996 ‎‡2 DNB|140733809
996 ‎‡2 SUDOC|201610361
996 ‎‡2 SUDOC|221509259
996 ‎‡2 DNB|109164598
996 ‎‡2 DNB|121155145
996 ‎‡2 DNB|118909908
996 ‎‡2 DNB|1328668959
996 ‎‡2 LC|no2010053543
996 ‎‡2 PLWABN|9810689230205606
996 ‎‡2 ISNI|0000000038419895
996 ‎‡2 DNB|173166261
996 ‎‡2 DNB|1037901568
996 ‎‡2 ISNI|0000000110841143
996 ‎‡2 LC|no2024104136
996 ‎‡2 ICCU|PUVV278097
996 ‎‡2 DNB|1047687119
996 ‎‡2 RERO|A026707864
996 ‎‡2 SZ|173166261
996 ‎‡2 DNB|141591064
996 ‎‡2 DBC|87097968915554
996 ‎‡2 DNB|131757830
996 ‎‡2 DNB|122508556
996 ‎‡2 LC|n 81129592
996 ‎‡2 DNB|121718778
996 ‎‡2 LC|no2014001942
996 ‎‡2 DNB|1274140331
996 ‎‡2 LC|n 95038663
996 ‎‡2 J9U|987007459176305171
996 ‎‡2 NSK|000239841
996 ‎‡2 ISNI|0000000067112411
996 ‎‡2 ISNI|0000000395553531
996 ‎‡2 ISNI|0000000369012678
996 ‎‡2 NKC|jo2012737874
996 ‎‡2 DNB|1349509167
996 ‎‡2 RERO|A003803604
996 ‎‡2 LC|n 00119295
996 ‎‡2 PLWABN|9811329465305606
996 ‎‡2 LC|no2014092993
996 ‎‡2 ICCU|PUVV288530
996 ‎‡2 SUDOC|251323641
996 ‎‡2 DNB|1176680005
996 ‎‡2 DNB|173331424
996 ‎‡2 DNB|136115748
996 ‎‡2 DNB|1081326514
996 ‎‡2 NTA|117926191
996 ‎‡2 LC|n 2003015068
996 ‎‡2 SZ|136531768
996 ‎‡2 BNF|17782077
996 ‎‡2 DNB|121617424
996 ‎‡2 J9U|987007267773805171
996 ‎‡2 DNB|119437953
996 ‎‡2 SUDOC|280508042
996 ‎‡2 NUKAT|n 2018042968
996 ‎‡2 BNF|16063672
996 ‎‡2 DNB|1236779053
996 ‎‡2 DNB|1219309931
996 ‎‡2 DNB|1128616513
996 ‎‡2 LC|n 2005071709
996 ‎‡2 DNB|1071823949
996 ‎‡2 NTA|072892730
996 ‎‡2 SZ|1132157390
996 ‎‡2 ISNI|0000000019391620
996 ‎‡2 LC|n 89139115
996 ‎‡2 DNB|117698974X
996 ‎‡2 DNB|1226720307
996 ‎‡2 LC|n 92101123
996 ‎‡2 DNB|1347929304
996 ‎‡2 ISNI|0000000391363183
996 ‎‡2 BIBSYS|90659637
996 ‎‡2 DNB|1347904611
996 ‎‡2 NII|DA17900108
996 ‎‡2 SUDOC|131567098
996 ‎‡2 LC|n 91128144
996 ‎‡2 ISNI|0000000118660718
996 ‎‡2 SUDOC|081095635
996 ‎‡2 NKC|mub2016917747
996 ‎‡2 DNB|122530608
996 ‎‡2 DNB|140255427
996 ‎‡2 LC|nr 95028606
996 ‎‡2 ISNI|0000000384580243
996 ‎‡2 DNB|1347925783
996 ‎‡2 RERO|A012431862
996 ‎‡2 NTA|330665197
996 ‎‡2 DNB|1033854123
996 ‎‡2 DNB|132203902X
996 ‎‡2 LC|n 79029658
996 ‎‡2 DNB|138871728
996 ‎‡2 DNB|1033584134
996 ‎‡2 BIBSYS|9054997
996 ‎‡2 ISNI|0000000403256378
996 ‎‡2 DNB|1347113487
996 ‎‡2 DNB|129664634
996 ‎‡2 SUDOC|138446237
996 ‎‡2 BNF|12383937
996 ‎‡2 DNB|1221229656
996 ‎‡2 SUDOC|085513598
996 ‎‡2 LC|no2014041219
996 ‎‡2 LC|n 2009180153
996 ‎‡2 SUDOC|145751457
996 ‎‡2 LIH|LNB:V-361942;=BL
996 ‎‡2 LNB|LNC10-000232503
996 ‎‡2 ISNI|000000040333185X
996 ‎‡2 DNB|125829981
996 ‎‡2 DNB|1346942161
996 ‎‡2 ISNI|0000000084683646
996 ‎‡2 LC|n 2018060737
996 ‎‡2 LC|n 94022995
996 ‎‡2 LC|no2024142367
996 ‎‡2 DNB|1047152827
996 ‎‡2 ISNI|0000000068018523
996 ‎‡2 ISNI|0000000021857733
996 ‎‡2 SELIBR|321062
996 ‎‡2 LC|n 80141212
996 ‎‡2 DNB|1136326545
996 ‎‡2 LC|n 78003368
996 ‎‡2 LC|no2005075353
996 ‎‡2 ISNI|0000000053897561
996 ‎‡2 NUKAT|n 00014934
996 ‎‡2 DNB|138147027
996 ‎‡2 NTA|074961268
996 ‎‡2 NUKAT|n 2014097671
996 ‎‡2 DNB|1032769742
996 ‎‡2 NTA|096158166
996 ‎‡2 LC|n 2010036127
996 ‎‡2 DNB|128434031
996 ‎‡2 ISNI|0000000070843135
996 ‎‡2 DNB|120877600
996 ‎‡2 LC|n 98034574
996 ‎‡2 ISNI|0000000070843223
996 ‎‡2 NSK|000177769
996 ‎‡2 LC|no2014066636
996 ‎‡2 LC|n 88636380
996 ‎‡2 CAOONL|ncf11612957
996 ‎‡2 BIBSYS|2085876
996 ‎‡2 NSK|000466528
996 ‎‡2 DNB|1183964234
996 ‎‡2 BNF|14599824
996 ‎‡2 NTA|375285016
996 ‎‡2 ISNI|0000000016550198
996 ‎‡2 DNB|1210512785
996 ‎‡2 LC|no2011048567
996 ‎‡2 RERO|A003803531
996 ‎‡2 RERO|A003803530
996 ‎‡2 DNB|1147013608
996 ‎‡2 RERO|A003803537
996 ‎‡2 RERO|A003803539
996 ‎‡2 RERO|A003803538
996 ‎‡2 DNB|142807060
996 ‎‡2 DNB|139871845
996 ‎‡2 NTA|07143738X
996 ‎‡2 NII|DA09893765
996 ‎‡2 DNB|1132157390
996 ‎‡2 BNE|XX1542094
996 ‎‡2 ISNI|0000000110269968
996 ‎‡2 BIBSYS|90659604
996 ‎‡2 LC|nr2006008618
996 ‎‡2 DNB|1347910131
996 ‎‡2 RERO|A026435793
996 ‎‡2 DNB|123124247
996 ‎‡2 SUDOC|073676004
996 ‎‡2 DNB|1057764728
996 ‎‡2 DNB|1259735532
996 ‎‡2 BIBSYS|4086114
996 ‎‡2 DNB|130002712
996 ‎‡2 NTA|323968627
996 ‎‡2 DNB|1056475412
996 ‎‡2 NTA|312838433
996 ‎‡2 J9U|987007267774205171
996 ‎‡2 DNB|1261036514
996 ‎‡2 DNB|106466881X
996 ‎‡2 DNB|1347113126
996 ‎‡2 RERO|A012135497
996 ‎‡2 NTA|072153121
996 ‎‡2 NSK|000618730
996 ‎‡2 DNB|1095805339
996 ‎‡2 DNB|140939105
996 ‎‡2 BIBSYS|90750852
996 ‎‡2 DNB|123205158
996 ‎‡2 DNB|1347160302
996 ‎‡2 LC|n 88638274
996 ‎‡2 DNB|1019903651
996 ‎‡2 DNB|140459952
996 ‎‡2 LC|nb2021000121
996 ‎‡2 DNB|122872959
996 ‎‡2 ISNI|000000037418698X
996 ‎‡2 ISNI|0000000023117878
996 ‎‡2 BNC|981058523739306706
996 ‎‡2 DNB|132854554
996 ‎‡2 DNB|129809306
996 ‎‡2 LIH|LNB:C29U;=1A
996 ‎‡2 DNB|1140803832
996 ‎‡2 NUKAT|nx2023895705
996 ‎‡2 DNB|1347905413
996 ‎‡2 LC|n 93032514
996 ‎‡2 BIBSYS|90068637
996 ‎‡2 RERO|A017395372
996 ‎‡2 BIBSYS|12040626
996 ‎‡2 NUKAT|n 2014182765
996 ‎‡2 BNF|12295653
996 ‎‡2 ISNI|0000000080235950
996 ‎‡2 ISNI|0000000020834230
996 ‎‡2 ISNI|0000000037852400
996 ‎‡2 DNB|119448041
996 ‎‡2 DNB|129775320
996 ‎‡2 DNB|122946146
996 ‎‡2 LC|n 2003094823
996 ‎‡2 LC|n 99051040
996 ‎‡2 CAOONL|ncf11239190
996 ‎‡2 DNB|1198901020
996 ‎‡2 DNB|1241355436
996 ‎‡2 BIBSYS|2067843
996 ‎‡2 ISNI|0000000077525316
996 ‎‡2 ISNI|0000000374487440
996 ‎‡2 DNB|1315510359
996 ‎‡2 DNB|1347140123
996 ‎‡2 DNB|1055778551
996 ‎‡2 DNB|130669164
996 ‎‡2 SZ|132854554
996 ‎‡2 DNB|1095667602
996 ‎‡2 NTA|073997838
996 ‎‡2 CAOONL|ncf10266346
996 ‎‡2 BIBSYS|90700922
996 ‎‡2 DNB|1201205131
996 ‎‡2 ISNI|0000000107981380
996 ‎‡2 DE633|pe30092051
996 ‎‡2 NUKAT|n 2008050203
996 ‎‡2 DNB|123124190
996 ‎‡2 ISNI|0000000109137343
996 ‎‡2 NUKAT|n 2012263558
996 ‎‡2 DNB|1283376148
996 ‎‡2 BIBSYS|3064472
996 ‎‡2 DNB|1022898523
996 ‎‡2 DNB|1323568255
996 ‎‡2 SZ|1198901020
996 ‎‡2 ISNI|0000000029589518
996 ‎‡2 ISNI|0000000076536742
996 ‎‡2 DNB|133325989
996 ‎‡2 ISNI|000000006708692X
996 ‎‡2 NDL|00455685
996 ‎‡2 CAOONL|ncf11419378
996 ‎‡2 BIBSYS|90934343
996 ‎‡2 DNB|111414696X
996 ‎‡2 DNB|1275783880
996 ‎‡2 PLWABN|9810692280505606
996 ‎‡2 NKC|jn19990007740
996 ‎‡2 NKC|jn19990007741
996 ‎‡2 DNB|1183299915
996 ‎‡2 DNB|1218486724
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏
998 ‎‡a Schneider, Thomas R.‏ ‎‡2 BIBSYS|9054997‏ ‎‡3 viafid‏
998 ‎‡a Schneider, Thomas R.‏ ‎‡2 DNB|132762446X‏ ‎‡3 standard number‏